Search results for "MiRNA"

showing 10 items of 190 documents

Alterations in Circulating miRNA Levels following Early-Stage Estrogen Receptor-Positive Breast Cancer Resection in Post-Menopausal Women

2014

INTRODUCTION: Circulating microRNAs (miRNAs) exhibit remarkable stability and may serve as biomarkers in several clinical cancer settings. The aim of this study was to investigate changes in the levels of specific circulating miRNA following breast cancer surgery and evaluate whether these alterations were also observed in an independent data set.METHODS: Global miRNA analysis was performed on prospectively collected serum samples from 24 post-menopausal women with estrogen receptor-positive early-stage breast cancer before surgery and 3 weeks after tumor resection using global LNA-based quantitative real-time PCR (qPCR).RESULTS: Numbers of specific miRNAs detected in the samples ranged fro…

Circulating mirnaslcsh:MedicineEstrogen receptorBreast NeoplasmsBioinformaticsBiochemistryBreast cancerSurgical oncologymicroRNABreast TumorsBreast CancermedicineMedicine and Health SciencesBiomarkers TumorHumansPostoperative PeriodStage (cooking)lcsh:Scienceskin and connective tissue diseasesAgedNeoplasm StagingAged 80 and overMultidisciplinarybusiness.industrylcsh:RCarcinoma Ductal BreastCancerBiology and Life SciencesCancers and NeoplasmsMiddle Agedmedicine.diseasePostmenopauseCirculating MicroRNAMicroRNAsOncologyReceptors Estrogenlcsh:QFemalebusinessBiomarkersResearch ArticlePLoS ONE
researchProduct

Liquid Biopsy in Diagnosis and Prognosis of High-Grade Gliomas; State-of-the-Art and Literature Review

2022

Gliomas, particularly high-grade gliomas, represent the most common and aggressive tumors of the CNS and are still burdened by high mortality and a very poor prognosis, regardless of the type of therapy. Their diagnosis and monitoring rely on imaging techniques and direct biopsy of the pathological tissue; however, both procedures have inherent limitations. To address these limitations, liquid biopsies have been proposed in this field. They could represent an innovative tool that could help clinicians in the early diagnosis, monitoring, and prognosis of these tumors. Furthermore, the rapid development of next-generation sequencing (NGS) technologies has led to a significant reduction in seq…

Circulating tumor DNAHigh-grade gliomaLiquid biopsySpace and Planetary ScienceSettore MED/27 - NeurochirurgiaNext-generation sequencingPaleontologyExtracellular vesiclesMiRNAGBMGeneral Biochemistry Genetics and Molecular BiologyEcology Evolution Behavior and Systematics
researchProduct

Assessing the impact of copy number variants on miRNA genes in autism by Monte Carlo simulation.

2014

Autism Spectrum Disorders (ASDs) are childhood neurodevelopmental disorders with complex genetic origins. Previous studies have investigated the role of de novo Copy Number Variants (CNVs) and microRNAs as important but distinct etiological factors in ASD. We developed a novel computational procedure to assess the potential pathogenic role of microRNA genes overlapping de novo CNVs in ASD patients. Here we show that for chromosomes # 1, 2 and 22 the actual number of miRNA loci affected by de novo CNVs in patients was found significantly higher than that estimated by Monte Carlo simulation of random CNV events. Out of 24 miRNA genes over-represented in CNVs from these three chromosomes only …

Clinical PathologyDNA Copy Number Variationsendocrine system diseasesChromosomes Human Pair 22ScienceGene regulatory networkGenomicsDevelopmental and Pediatric NeurologyBiologyPathology and Laboratory MedicinePediatricsGenomeMolecular GeneticsmiRNA Genes Monte Carlo Simulation AutismDiagnostic Medicinemental disordersGeneticsMedicine and Health SciencesmedicineHumansComputer SimulationGene Regulatory NetworksCopy-number variationAutistic DisorderGeneGeneticsMultidisciplinaryGenome HumanQRBiology and Life SciencesComputational BiologyGenomicsGenome Analysismedicine.diseaseSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)MicroRNAsNeurologyChromosomes Human Pair 1Genetic LociAutism spectrum disorderChromosomes Human Pair 2AutismMedicineStructural GenomicsHuman genomeMonte Carlo MethodResearch ArticlePLoS ONE
researchProduct

The Potential Role of miRNAs in Cognitive Frailty.

2021

Frailty is an aging related condition, which has been defined as a state of enhanced vulnerability to stressors, leading to a limited capacity to meet homeostatic demands. Cognitive impairment is also frequent in older people, often accompanying frailty. Age is the main independent risk factor for both frailty and cognitive impairment, and compelling evidence suggests that similar age-associated mechanisms could underlie both clinical conditions. Accordingly, it has been suggested that frailty and cognitive impairment share common pathways, and some authors proposed “cognitive frailty” as a single complex phenotype. Nevertheless, so far, no clear common underlying pathways have been discove…

Cognitive frailtyAgingbiomarkers cognitive frailty cognitive impairment frailty MCI (mild cognitive impairment) miRNA–microRNACognitive NeuroscienceVulnerabilitycognitive frailtyNeurosciences. Biological psychiatry. NeuropsychiatryReviewfrailtyMCI (mild cognitive impairment)MCI (mild cognitive impairment); biomarkers; cognitive frailty; cognitive impairment; frailty; miRNA–microRNAmicroRNAMedicinePathologicalcognitive impairmentbusiness.industryStressorbiomarkers; cognitive frailty; cognitive impairment; frailty; MCI (mild cognitive impairment); miRNA–microRNAbiomarkersCognitionPhenotypemiRNA–microRNAPotential biomarkersbiomarkerbusinessNeuroscienceRC321-571NeuroscienceFrontiers in aging neuroscience
researchProduct

MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy

2019

Myotonic dystrophy involves two types of chronically debilitating rare neuromuscular diseases: type 1 (DM1) and type 2 (DM2). Both share similarities in molecular cause, clinical signs, and symptoms with DM2 patients usually displaying milder phenotypes. It is well documented that key clinical symptoms in DM are associated with a strong mis-regulation of RNA metabolism observed in patient’s cells. This mis-regulation is triggered by two leading DM-linked events: the sequestration of Muscleblind-like proteins (MBNL) and the mis-regulation of the CUGBP RNA-Binding Protein Elav-Like Family Member 1 (CELF1) that cause significant alterations to their important functions in RNA processing. It ha…

Context (language use)miRNA-based drugReviewBioinformaticsMyotonic dystrophyCatalysislcsh:ChemistryInorganic ChemistryMBNL proteinsCELF1microRNADrug DiscoveryMedicineAnimalsHumansPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopyCELF1 ProteinRna processingmyotonic dystrophymicroRNAbusiness.industryOrganic ChemistryAlternative splicingmiRNA-targeting drugRNA-Binding ProteinsGeneral MedicineGenetic Therapymedicine.diseasePhenotypeComputer Science ApplicationsAlternative SplicingMicroRNAslcsh:Biology (General)lcsh:QD1-999Drug developmentGene Expression Regulationantisense oligonucleotidesbusinessFunction (biology)International Journal of Molecular Sciences
researchProduct

Dynamic architecture and regulatory implications of the miRNA network underlying the response to stress in melon

2019

miRNAs are small RNAs that regulate mRNAs at both transcriptional and posttranscriptional level. In plants, miRNAs are involved in the regulation of different processes including development and stress-response. Elucidating how stress-responsive miRNAs are regulated is key to understand the global response to stress but also to develop efficient biotechnological tools that could help to cope with stress. Here, we describe a computational approach based on sRNA sequencing, transcript quantification and degradome data to analyse the accumulation, function and structural organization of melon miRNAs reactivated under seven biotic and abiotic stress conditions at two and four days post-treatmen…

Crops AgriculturalMelonTranscript quantificationPeriod (gene)Computational biologyBiologyRegulation of the stress response in crops03 medical and health sciences0302 clinical medicineGene Expression Regulation PlantStress PhysiologicalStress (linguistics)microRNAGene Regulatory NetworksGene SilencingMolecular Biology030304 developmental biology0303 health sciencesStructural organizationAbiotic stressCell BiologyMicroRNAsCucurbitaceaeRNA silencingPhenotypemiRNA networks030220 oncology & carcinogenesissRNAs analisysRNA InterferenceRNA silencingFunction (biology)Research PaperRNA Biology
researchProduct

The molecular changes driving the carcinogenesis in Barrett's esophagus: which came first, the chicken or the egg?

2013

Esophageal adenocarcinoma originates from columnar metaplastic epithelium of the distal esophagus. Various steps for this carcinogenetic process are known. Before the onset of high-grade dysplasia and adenocarcinoma, endoscopic surveillance is possible. However, because of the high cost of long-term surveillance, predictive factors for cancer are being evaluated to identify subjects with metaplasia who have a higher risk of developing malignancy. Molecular changes seem suitable for this purpose, but could require a high resource expenditure. While trying to identify the best predictive factors for cancer risk, molecular changes and differences in miRNA expression profile between the various…

DysplasiaPathologymedicine.medical_specialtyEsophageal NeoplasmsSettore MED/06 - Oncologia MedicaCarcinogenesisSettore MED/08 - Anatomia PatologicaAdenocarcinomaMalignancymedicine.disease_causeBarrett EsophagusMetaplasiamicroRNAmedicineHumansMetaplasiabusiness.industryEndoscopic surveillanceCancerBarrett's esophaguBarrett's esophagus; Metaplasia; Dysplasia; Adenocarcinoma; Endoscopic surveillance; miRNAsHematologymedicine.diseaseSettore MED/18 - Chirurgia GeneraleMicroRNAsOncologyDysplasiaBarrett's esophagusmiRNAsCancer researchDisease ProgressionAdenocarcinomamedicine.symptombusinessCarcinogenesisBiomarkersCritical reviews in oncology/hematology
researchProduct

Non-coding RNAs and Coronary Artery Disease

2020

Coronary artery disease (CAD) is the leading death cause worldwide. Non-coding RNA (ncRNA) are key regulators of genetic expression and thus can affect directly or indirectly the development and progression of different diseases. ncRNA can be classified in several types depending on the length or structure, as long non-coding RNA (lncRNA), microRNA (miRNA) and circularRNA (circRNA), among others. These types of RNA are present within cells or in circulation, and for this reason they have been used as biomarkers of different diseases, therefore revolutionizing precision medicine. Recent research studied the capability of circulating ncRNA to inform about CAD presence and predict the outcome …

Enfermedad cardiovascularRNABiomarkerDiseaseComputational biologyGenética humanaBiologyNon-coding RNAPrecision medicinemedicine.diseaseARNCoronary artery disease (CAD)Coronary artery disease03 medical and health scienceslncRNA0302 clinical medicineBiomarker; Coronary artery disease (CAD); circRNA; lncRNA; miRNAGene expressionmicroRNAmedicineBiomarker (medicine)Cardiopatía coronariacircRNA030212 general & internal medicinemiRNA
researchProduct

Epigenetic biomarkers: A new perspective in laboratory diagnostics.

2012

Epigenetics comprises the study of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. However, during the last decade this term has evolved after the elucidation of different mechanisms (microRNAs and nuclear organization of the chromosomes) involved in regulating gene expression. Epigenetics and the new designed technologies capable to analyze epigenetic changes (e.g., methylated DNA, miRNAs expression, post-translational modifications on histones among others) have disclosed an appealing scenario that will offer for the biomedical sciences new biomarkers for the study of neurodegenerative diseases, multifactorial complex diseases, rare…

EpigenomicsClinical BiochemistryBiologyBiochemistryEpigenesis GeneticHistonesmicroRNACancer; DNA methylation; Histone; MiRNAs; Rare disease;HumansEpigeneticsPathology MolecularEpigenesisEpigenomicsCancerGeneticsEpigenetic biomarkersBiochemistry (medical)Nuclear organizationGeneral MedicineSequence Analysis DNADNA MethylationHistoneMicroRNAsHistoneDNA methylationbiology.proteinMiRNAsRare diseaseProtein Processing Post-TranslationalBiomarkersClinica chimica acta; international journal of clinical chemistry
researchProduct

Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer

2015

Metastasis is the main cause of cancer mortality. One of the initiating events of cancer metastasis of epithelial tumors is epithelial-to-mesenchymal transition (EMT), during which cells dedifferentiate from a relatively rigid cell structure/morphology to a flexible and changeable structure/morphology often associated with mesenchymal cells. The presence of EMT in human epithelial tumors is reflected by the increased expression of genes and levels of proteins that are preferentially present in mesenchymal cells. The combined presence of these genes forms the basis of mesenchymal gene signatures, which are the foundation for classifying a mesenchymal subtype of tumors. Indeed, tumor classifi…

Epithelial-Mesenchymal TransitionReviewBiologyBioinformaticsMetastasis03 medical and health sciences0302 clinical medicinemicroRNAGene expressionmedicineHumanscancerEpithelial–mesenchymal transitionCystadenocarcinomaGene030304 developmental biologyOvarian Neoplasms0303 health sciencesMessenger RNAmiR-506Mesenchymal stem cellmiR-101medicine.diseaseCystadenocarcinoma Serous3. Good healthMicroRNAsOncology030220 oncology & carcinogenesisCancer researchFemaleovaryMicroRNA (miRNA)epithelial-to-mesenchymal transition (EMT)Chinese Journal of Cancer
researchProduct